Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial-Reference-Cited by-同舟云学术

Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

Published:2019-11-08 Issue:2 Volume:125 Page:215-225
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Macias Victor A.¹²^ORCID,Barrera-Mellado Inmaculada³

Affiliation:

1. Radiation Oncology Department; Hospital Universitario y Politécnico La Fe; Valencia Spain

2. Hospital Universitario de Salamanca; Salamanca Spain

3. Statistics Department; University of Salamanca; Salamanca Spain

Funder

Castilla-Leon Public Health Service

American Society for Radiation Oncology

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14925/fullpdf

Reference40 articles.

1. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial;Widmark;Lancet,2009

2. Long-term results of the Dutch randomized prostate cancer trial: impact of dose-escalation on local, biochemical, clinical failure, and survival;Heemsbergen;Radiother Oncol,2014

3. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol,2008

4. Conventional versus hypofractionated radiation therapy for localized prostate cancer: a meta-analysis of randomized noninferiority trials;Royce;Eur Urol Focus,2017

5. ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer;Rodda;Int J Radiat Oncol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study;Frontiers in Oncology;2023-11-08

3. Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer;Cancer Imaging;2023-01-04

4. The Journey of Radiotherapy Dose Escalation in High Risk Prostate Cancer; Conventional Dose Escalation to Stereotactic Body Radiotherapy (SBRT) Boost Treatments;Clinical Genitourinary Cancer;2022-02

5. Practical considerations for prostate hypofractionation in the developing world;Nature Reviews Urology;2021-08-13